St. Louis, Missouri (PRWEB) January 27, 2014 The Ethicon multidistrict litigation (MDL), which is being heard in a West Virginia federal court, continues to make significant progress early in this…
Read More
C.R. Bard offered a $21 million transvaginal mesh lawsuit settlement that could impact around 500 cases. The plaintiffs who filed these lawsuits against C.R. Bard did so after sustaining serious…
Read More
The latest from the West Virginia transvaginal mesh multidistrict litigations (MDLs) involves the case of Linda Rizzo, a plaintiff who removed her case from the C. R. Bard MDL in…
Read More
Carey Danis & Lowe continues to follow the C.R. Bard multidistrict litigation (MDL) in a West Virginia federal court. In a court document filed in early December, Judge Joseph R.…
Read More
The California Supreme Court recently denied the appeal of a transvaginal mesh manufacturer, C.R. Bard, who sought to annul a 2012 jury verdict awarding $5.5 million to the plaintiff in…
Read More
3,000 transvaginal mesh lawsuits could soon be resolved. Boston Scientific proposed a $119 million transvaginal mesh settlement. The medical device manufacturer included the settlement in an SEC filing in late…
Read More
Boston Scientific, the company behind such products as Pinnacle transvaginal mesh, must pay $26.7 million in a transvaginal mesh lawsuit in Miami. After a deliberation period lasting only a few…
Read More
In the second federal transvaginal mesh lawsuit to go to trial, Boston Scientific was dealt another verdict requiring them to compensate plaintiffs. After deliberating for over six hours, the jury…
Read More
How can you make the right decision without proper direction? Many women have asked themselves that question after their life-changing experiences using Yaz, Yasmin, or Ocella. These women suffered serious…
Read More
Hundreds of women in Australia are considering filing a class action lawsuit targeted at Bayer, the pharmaceutical company behind the contraceptive pills Yaz and Yasmin. The latest reports estimate that…
Read More